Indian drug makers wary as US FDA sharpens focus on quality controlPost published:May 16, 2017Post category:Industry NewsThe US FDA has increased the frequency of its inspections but also intensified scrutiny on drug manufacturing facilities in India Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostFacebook’s Sheryl Sandberg urges family-friendly policies on Mother’s Day Next PostLithium supply may be key to government’s electric vehicles push You Might Also Like Leuze introduces TPE and PVC Yellow sheathed cables May 30, 2019 How Viable is Additive Manufacturing? October 17, 2019 Abaco Systems announces SBC3511 3U OpenVPX single board computer April 9, 2019